Shan Xiaoqin, Li Siyi, Liu Jiayi, Wang Can, Wei Yao, Shi Jiayi, Zhang Xinyue, Gu Lili
Key Laboratory of Neuropsychiatric Drug Research of Zhejiang Province, Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China.
Pharmacol Res Perspect. 2025 Oct;13(5):e70161. doi: 10.1002/prp2.70161.
Andrographolide, a diterpenoid component found in traditional Chinese medicine Andrographis paniculata, is known as a natural antibiotic and can be used to treat inflammatory lesions of various systemic diseases. In recent years, andrographolide derivatives have been continuously synthesized and have shown good anti-inflammatory pharmacological activity. These derivatives are mainly obtained by chemical synthesis methods, for example, by altering the hydroxyl and double bond groups in the molecule of andrographolide and introducing different substituents, thus obtaining derivatives with different biological activities and pharmacological properties. This paper summarizes the anti-inflammatory mechanism of andrographolide derivatives and the progress of pharmacological research in inflammatory diseases, such as viral infectious diseases, respiratory or lung injury, gastrointestinal diseases, liver injury, and neurological disorders. It also incorporates the results of our own team's research to deeply explore their therapeutic potential in different inflammatory diseases, which provides direction and rationale for in-depth follow-up research.
穿心莲内酯是传统中药穿心莲中的一种二萜类成分,被誉为天然抗生素,可用于治疗各种全身性疾病的炎症性病变。近年来,穿心莲内酯衍生物不断被合成,并显示出良好的抗炎药理活性。这些衍生物主要通过化学合成方法获得,例如,通过改变穿心莲内酯分子中的羟基和双键基团并引入不同的取代基,从而获得具有不同生物活性和药理特性的衍生物。本文综述了穿心莲内酯衍生物的抗炎机制以及在病毒性传染病、呼吸道或肺损伤、胃肠道疾病、肝损伤和神经紊乱等炎症性疾病中的药理研究进展。此外,还纳入了我们团队的研究结果,以深入探讨它们在不同炎症性疾病中的治疗潜力,为深入的后续研究提供方向和理论依据。
Pharmacol Res Perspect. 2025-10
Curr Med Chem. 2024-6-11
Mediators Inflamm. 2025-7-23
Phytomedicine. 2023-1
Arch Ital Urol Androl. 2025-6-30
JBJS Essent Surg Tech. 2025-8-15
Cochrane Database Syst Rev. 2021-4-19
Front Immunol. 2024
Clin Transl Med. 2024-8
Biomed Pharmacother. 2024-7
Phytomedicine. 2024-7-25